GeneMeta Biotech LLC
Startup
At the forefront of the DNA synthetic biology industry, GeneMeta Biotech LLC is revolutionizing biotech with significant advances in large-scale gene synthesis. With a specialization in gene synthesis, DNA storage, bio-manufacturing, and the establishment of a full-chain synthetic biology industrialization platform, the company is pushing the boundaries of the field.
GeneMeta's cutting-edge technology has placed it at the forefront of the industry, and its dedicated gene synthesis facility is ready to provide industrial-standard services of the highest quality. The facility spans over 30,000 square feet and offers a range of services, including gene synthesis, large DNA synthesis, plasmid preparation, and more.
GeneMeta is known for its innovative approach to gene synthesis, particularly in the range of 10kb to 250kb. By providing specialized services in this area, the company has become a leader in the field. GeneMeta's commitment to advancing synthetic biology is evident in its establishment of a full-chain synthetic biology industrialization platform.
The use of DNA synthesis technology has become increasingly important in the vaccine industry, particularly for the development of novel vaccine candidates. We aspire to acquire additional prospective customers
GeneMeta's cutting-edge technology has placed it at the forefront of the industry, and its dedicated gene synthesis facility is ready to provide industrial-standard services of the highest quality. The facility spans over 30,000 square feet and offers a range of services, including gene synthesis, large DNA synthesis, plasmid preparation, and more.
GeneMeta is known for its innovative approach to gene synthesis, particularly in the range of 10kb to 250kb. By providing specialized services in this area, the company has become a leader in the field. GeneMeta's commitment to advancing synthetic biology is evident in its establishment of a full-chain synthetic biology industrialization platform.
The use of DNA synthesis technology has become increasingly important in the vaccine industry, particularly for the development of novel vaccine candidates. We aspire to acquire additional prospective customers
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events